Tumour necrosis factor and cancer

F Balkwill - Nature reviews cancer, 2009 - nature.com
Tumour necrosis factor (TNF) is a major inflammatory cytokine that was first identified for its
ability to induce rapid haemorrhagic necrosis of experimental cancers. When efforts to …

Role of cytokines in rheumatoid arthritis

M Feldmann, FM Brennan… - Annual review of …, 1996 - annualreviews.org
▪ Abstract Analysis of cytokine mRNA and protein in rheumatoid arthritis tissue revealed that
many proinflammatory cytokines such as TNFα, IL-1, IL-6, GM-CSF, and chemokines such …

[HTML][HTML] Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes

MF McDermott, I Aksentijevich, J Galon, EM McDermott… - Cell, 1999 - cell.com
Autosomal dominant periodic fever syndromes are characterized by unexplained episodes
of fever and severe localized inflammation. In seven affected families, we found six different …

Interleukin-1 and interleukin-1 antagonism

CA Dinarello - 1991 - ashpublications.org
The polypeptide cytokine interleukin-1 (IL-1) affects nearly every tissue and organ system. IL-
1 is the prototype of the pro-inflammatory cytokines in that it induces the expression of a …

Anti-TNFα therapy of rheumatoid arthritis: what have we learned?

M Feldmann, RN Maini - Annual review of immunology, 2001 - annualreviews.org
Rheumatoid arthritis (RA), a systemic disease, is characterized by a chronic inflammatory
reaction in the synovium of joints and is associated with degeneration of cartilage and …

Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55

H Tilg, E Trehu, MB Atkins, CA Dinarello, JW Mier - 1994 - ashpublications.org
The aim of this study was to investigate whether interleukin (IL)-6 induces the production of
IL-1 and tumor necrosis factor (TNF) antagonists. Serial plasma samples were obtained from …

Etanercept therapy in rheumatoid arthritis: a randomized, controlled trial

LW Moreland, MH Schiff, SW Baumgartner… - Annals of internal …, 1999 - acpjournals.org
Background: In a phase II study, etanercept (recombinant human tumor necrosis factor
receptor [p75]: Fc fusion protein) safely produced rapid, dose-dependent improvement in …

Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein

CJ Fisher Jr, JM Agosti, SM Opal… - … England Journal of …, 1996 - Mass Medical Soc
Background A recombinant, soluble fusion protein that is a dimer of an extracellular portion
of the human tumor necrosis factor (TNF) receptor and the Fc portion of IgG1 (TNFR: Fc) …

Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)–Fc fusion protein

LW Moreland, SW Baumgartner… - … England Journal of …, 1997 - Mass Medical Soc
Background Tumor necrosis factor (TNF) is a proinflammatory cytokine involved in the
pathogenesis of rheumatoid arthritis, and antagonism of TNF may reduce the activity of the …

Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial

WJ Sandborn, SB Hanauer, S Katz, M Safdi, DG Wolf… - Gastroenterology, 2001 - Elsevier
Background & Aims: We evaluated etanercept, a human soluble tumor necrosis factor
receptor: Fc fusion protein, for the treatment of active Crohn's disease. Methods: Forty-three …